Blogs about ALXN - Stockpickr! Your Source for Stock Ideas

Blogs about ALXN

Blogs	Description	Date Updated
Baby Teeth, Stem Cells, and Stocks	What do baby teeth, stem cells and stocks have in common? The National Institute of Health has discovered that strong stem cells can be found in baby teeth, and there are stocks of several companies involved in stem cell research. Last month, a dental practice management company in Houston announced that they will offer a service of storing stem cells from baby teeth. Extensive research is being done to utilize stem cells for gene therapy and the treatment of multiple sclerosis, Parkinson’s di...	June 18, 2008
Analyst initiations: BEC, BT and MITI	Filed under: Yahoo! (YHOO), Analyst initiationsMOST NOTEWORTHY: Beckman Coulter, BT Group and Micromet were today's noteworthy initiations: Oppenheimer believes Beckman Coulter (NYSE:BEC) is well-positioned to leverage its broad installed base in the clinical lab market to increase sales of its consumable and a new molecular diagnostics instrument expected in 2010. The firm initiated shares with an Outperform rating and $80 target. Societe Generale expects BT Group's (NYSE:BT) dom...	May 29, 2008
Tuesday's Upgrades and Downgrades	UpgradesCoStar Group (CSGP)- Ferris Baker Watts Neutral » Buy Peet's Coffee (PEET)- Wedbush Morgan Hold » Buy Clear Channel Outdoor (CCO)- Barrington Research Mkt Perform » Outperform Cognex (CGNX)- Needham & Co Buy » Strong Buy Safeway (SWY)- Banc of America Sec Neutral » Buy Canadian Solar (CSIQ)- Piper Jaffray Neutral » Buy Alon USA Energy (ALJ)- Caris & Company Above Average » Buy Sprint Nextel (S )- HSBC Securities Underweight » Neutral Patters...	February 19, 2008
Analyst downgrades: Coal sector, independent refiners and ALXN	Filed under: Analyst upgrades and downgrades, Whole Foods Market (WFMI)MOST NOTEWORTHY: The coal sector, independent refiners and Alexion Pharmaceuticals were today's noteworthy downgrades: Goldman downgraded the coal sector to Cautious from Neutral, citing valuations and expectations for lower coal prices. The firm downgraded CONSOL Energy (NYSE: CNX) Peabody Energy (NYSE: BTU) to Neutral from Buy and Arch Coal (NYSE: ACI) to Sell from Neutral. Lehman downgraded independent refiner...	February 15, 2008
Pre-Market Stock News (June 22, 2007)	(ADM) ADM is entering the sugarcane ethanol business in Brazil.(ALXN) Alexion Pharmaceuticals was granted marketing approval in Europe for its PNH treatment.(AMN) Ameron announced dividend boost from $0.20 to $0.25e.(BSC) Bear Stearns is planning a $3.2 Billion loan to try to rescue a distressed fund.(BX) Blackstone IPO priced at $31.00.(ETN) Eaton selling its mirror controls business for $111 million.(GRRF) China Grentech will supply WiFi equipment for China Mobile’s Olympic wireless LAN.(JBL...	June 22, 2007
Pre-Market Stock News (June 11, 2007)	(ADLR) Adolor said a complete response to the POI ‘Approvable’ Letter now targeted for 3Q 2007.(ALXN) Alexion Pharm says studies show efficacy and safety of it's Soliris in broad population of PNH patients in Phase III studies examining Soliris for the treatment of paroxysmal nocturnal hemoglobinuria.(BYBI) Backyard Burgers agrees to be acquired for $6.50 cash per share.(CHINA) CDC Corp making a gaming company acquisition.(CSGS) CSG Systems is paying $23.5M cash to acquire private ComTec.(CU...	June 11, 2007
Loeb's Third Point Shows A Number of New Positions in Latest 13F	Third Point LLC, run by activist investors Daniel Loeb, released its 13F for the quarter ended March 31, 2007 yesterday afternoon.Some interesting new positions from the filing:Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) 350,000 sharesAlexion Pharmaceuticals Inc. (Nasdaq: ALXN) 400,000 sharesAlkermes, Inc. (Nasdaq: ALKS) 750,000 sharesAriad Pharmaceuticals Inc. (Nasdaq: ARIA) 1,600,000 sharesATP Oil & Gas Corp. (Nasdaq: ATPG) 2,000,000 shares (already known from 13G)BearingPoint (NYSE: BE) 3,...	May 16, 2007
The Rising Cost of Healthcare Taken To Another Extreme	By Chad Brand of Peridot Capitalist LOS ANGELES, March 26 (Reuters) - Shares of Alexion Pharmaceuticals Inc. (ALXN) rose more than 9 percent on Monday after the company told analysts that its treatment for a rare blood disorder would be priced at $389,000 per year. The drug, Soliris, was approved earlier this month as the first product to treat paroxysmal nocturnal hemoglobinuria (PNH), a condition that affects fewer than 200,000 people in the United States. "We considered many fa...	March 30, 2007
Pre-Market Stock News (MAR 19, 2007)	(ABN) ABN AMRO is in an informal acquisition round of talks where Barclays would acquire the company.(ALXN) Alexion Pharma gets FDA marketing approval for Soliris.(ANPI) Angiotech Pharma announces the initiation of its United States study examining the Vascular Wrap Paclitaxel-Eluting Mesh.(ANLT) Analytical Surveys to merge with Ecowood.(AVZA) Aviza Tech received an order for its Sigma fxP physical vapor deposition system from Cension Semiconductor Manufacturing.(CAT) Caterpillar indicated up on...	March 19, 2007
Market highlights for next week: Nortel, Adobe, Oracle to report	Filed under: Earnings reports, Press releases, Products and services, Conventions and conferences, Annual meetings, Starbucks (SBUX), Adobe Systems (ADBE), NIKE, Inc'B' (NKE), Verizon Communications (VZ), Oracle Corp (ORCL), Nortel Networks (NT), QUALCOMM Inc (QCOM), Broadcom Corp'A' (BRCM)Monday March 19 Nortel Networks Corporation (NYSE: NT) to report Q4 earnings; conference call at 8:30am. Analysts will be focused on Nortel's Mobility enterprise solutions revenue, as well as new business...	March 16, 2007

Enter search text here: